Baxter International BAX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Baxter International (BAX) Business Model and Operations Summary
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
Key Insights
Baxter International (BAX) Core Market Data and Business Metrics
Latest Closing Price
$27.84Market Cap
$14.21 BillionAverage Daily Trade Volume
4,812,251 SharesTotal Outstanding Shares
510.59 Million SharesCEO
Mr. David Brent ShaferTotal Employees
60,000Dividend
$0.17 Per Share QuarterlyIPO Date
May 15, 1961SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
One Baxter Pkwy, Deerfield, IL, 60015
Historical Stock Splits
| Execution Date | Split Amount |
|---|
Short Interest
Short Interest
This information is bi-monthly aggregated short interest data reported to the Financial Industry Regulatory Authority (FINRA) by broker-dealers.
Short Interest: The total number of shares that have been sold short but have not yet been covered or closed out.
Settlement Date: The date on which the short interest data is considered settled, typically based on exchange reporting schedules.
Bi-Weekly Change (%): The percentage change in short interest from the previous bi-weekly period.
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Short Interest | Settlement Date | Bi-Weekly Change (%) |
|---|---|---|
| 18.16 Million Shares | 3/31/2025 | -0.93% |
| 18.33 Million Shares | 3/14/2025 | -12.68% |
| 20.99 Million Shares | 2/28/2025 | +17.75% |
| 17.83 Million Shares | 2/14/2025 | +2.16% |
| 17.45 Million Shares | 1/31/2025 | +4.23% |
| 16.74 Million Shares | 1/15/2025 | +30.39% |
Historical Dividends
Current dividend: $0.17 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 11, 2025 | Apr 1, 2025 | Feb 28, 2025 | $0.17 | Quarterly |
| Nov 11, 2024 | Jan 2, 2025 | Nov 29, 2024 | $0.17 | Quarterly |
| Jul 16, 2024 | Oct 1, 2024 | Aug 30, 2024 | $0.29 | Quarterly |
| May 7, 2024 | Jul 1, 2024 | May 31, 2024 | $0.29 | Quarterly |
| Feb 12, 2024 | Apr 1, 2024 | Mar 1, 2024 | $0.29 | Quarterly |
| Nov 14, 2023 | Jan 2, 2024 | Dec 1, 2023 | $0.29 | Quarterly |